During the past decade, Rhumatologie, CHR du MANS conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rhumatologie, CHR du MANS" #1 collaborator was "Ministry for Health and Solidarity, France" with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Rhumatologie, CHR du MANS" are "Rheumatoid Arthritis" (2 trials), "Ankylosing Spondylitis" (1 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Rhumatologie, CHR du MANS" in a lesser frequency.

Most popular intervention types in "Rhumatologie, CHR du MANS" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Adalimumab" (1 trials), "Metformin treatment" (1 trials), "Methotrexate" (1 trials) and "Methotrexate treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rhumatologie, CHR du MANS" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Rhumatologie, CHR du MANS". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Rhumatologie, CHR du MANS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rhumatologie, CHR du MANS, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".